Scinnohub Pharmaceutical Co., Ltd.

This study is testing a new injection called BT-114143 for women who experience abnormally heavy menstrual bleeding. The main goals are to check if the injection is safe at different doses and to see if it can effectively reduce the amount of blood loss. Researchers will also mea…

This study is testing whether a new drug called BT-114143 can safely reduce blood loss during and after knee replacement surgery. It will compare two different doses of the new drug against a standard medication (tranexamic acid) in 270 adults having the surgery. The main goal is…